cephalosporin c has been researched along with cefzil in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (8.52) | 18.7374 |
| 1990's | 108 (61.36) | 18.2507 |
| 2000's | 37 (21.02) | 29.6817 |
| 2010's | 13 (7.39) | 24.3611 |
| 2020's | 3 (1.70) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, D; Itoh, S; Kanazashi, S; Mayumi, M; Mikawa, H; Mochizuki, Y; Ohkubo, H | 1 |
| Higashino, H; Kawasaki, H; Kino, M; Kobayashi, Y; Kohdera, U; Nakamura, M; Woo, M | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Okura, K; Tsutsui, T | 1 |
| Kouzan, H; Murakawa, K; Nishimori, M; Ohara, K; Okamoto, T; Sekiguchi, T; Shiino, Y | 1 |
| Furukawa, S; Okada, T | 1 |
| Ito, M; Kuroda, Y; Takeda, E | 1 |
| Kainou, Y; Kida, K; Matsuda, H; Matsumoto, S | 1 |
| Araki, K; Fujieda, M; Kido, S; Kurashige, T; Nomura, I; Ohishi, N; Takechi, T; Takeda, K; Wakiguchi, H; Yoshimura, K | 1 |
| Aramaki, M; Kawakami, A; Koga, T; Matsukuma, Y; Motohiro, T; Oda, K; Sakata, Y; Tanaka, K; Tomita, S; Yamashita, F | 1 |
| Aramaki, M; Kawakami, A; Koga, T; Motohiro, T; Oda, K; Okabayashi, S; Sakata, Y; Takajo, N; Tomita, S; Yamashita, F | 1 |
| Fukuda, S; Imamura, H; Maeda, H; Nagano, K; Nakayama, N; Tsuji, Y; Yanagi, T; Yanagishima, M | 1 |
| Graham, DY; Klein, PD; Malaty, H | 1 |
| Barbhaiya, RH; Campbell, DA; Pittman, KA; Shah, VR; Shyu, WC; Wilber, RB | 1 |
| Arias, G; Bolaños, HJ; Faingezicht, I; Guevara, J; Ruiz, M | 1 |
| Barbhaiya, RH; Pittman, KA; Shukla, UA | 1 |
| Kidono, M; Nakanomyo, H; Shimizu, N; Shiraya, M | 1 |
| Akita, H; Ikeda, M; Isohata, E; Iwata, S; Kin, Y; Kusumoto, Y; Nanri, S; Oikawa, T; Sato, Y; Yamada, K | 1 |
| Iwai, N; Nakamura, H | 1 |
| Abe, T; Meguro, H; Shiraishi, H; Tajima, T | 1 |
| Matsumoto, K; Nakazawa, S; Narita, A; Niinou, K; Sato, H; Suzuki, H | 1 |
| Akita, H; Iwata, S; Sato, Y; Sunakawa, K | 1 |
| Iwai, N; Kasai, K; Miyazu, M; Nakamura, H | 1 |
| Ando, H; Ando, Y; Hayakawa, F; Kuno, K; Nakao, Y; Ogawa, A | 1 |
| Arai, S; Ihara, T; Inoue, M; Ito, M; Kamiya, H; Kojima, M; Nishi, H; Sakurai, M; Shimizu, S; Sono, R | 1 |
| Aoki, S; Nishimura, T; Tabuki, K; Takagi, M | 1 |
| Abe, T; Fujii, R; Matsumoto, K; Meguro, H; Nakazawa, S; Niinou, K; Sato, H; Shiraishi, H; Sunakawa, K; Tajima, T | 1 |
| Barbhaiya, RH; Campbell, DA; Jaganathan, V; Pittman, KA; Shah, VR; Shyu, WC; Venitz, J; Wilber, RB | 1 |
| Barbhaiya, RH; Pittman, KA; Shyu, WC; Wilber, RB | 1 |
| Borner, K; Koeppe, P; Lode, H; Müller, C; Nord, CE | 1 |
| Syrop, J | 1 |
| Klein, JO | 1 |
| Barriere, SL | 2 |
| Thornsberry, C | 1 |
| Arguedas, AG; Stutman, HR | 1 |
| McCarty, JM; Renteria, A | 1 |
| Pelletier, LL | 1 |
| Nolen, TM | 1 |
| Conetta, BJ; DeGraw, SS; Doyle, CA; Durham, SJ; Leigh, A; Wilber, RB | 1 |
| Barbhaiya, RH; Pittman, KA; Shyu, WC; Wang, L | 1 |
| Christenson, JC; Gooch, WM; Herrod, JN; Swenson, E | 2 |
| Doyle, C; Fung-Tomc, J; Huczko, E; Kessler, RE; Stickle, T | 1 |
| Miyake, Y; Nishimoto, K; Suginaka, H; Usui, T | 1 |
| Akaniro, JC; Arguedas, AG; Arrieta, AC; Marks, MI; Stutman, HR | 1 |
| Arguedas, AG; Blumer, JL; Hains, CS; Stutman, HR; Zaleska, M | 1 |
| Barbhaiya, RH; Papp, EA; Shah, VR; Shukla, UA; Shyu, WC | 1 |
| Iravani, A | 1 |
| Barbhaiya, RH; Matzke, GR; Pittman, KA; Shyu, WC; Wilber, RB | 1 |
| Barbhaiya, RH; Garg, DC; Pittman, KA; Shyu, WC; Wilber, RB | 1 |
| Kumiesz, H; Nelson, J; Sáez-Llorens, X; Shelton, S; Shyu, WC | 1 |
| Chikazawa, H; Ishikawa, K; Kadota, T; Kai, S; Kawano, S; Kohmura, H; Kondoh, H; Kuroyanagi, K; Ohta, S; Takahashi, N | 2 |
| Akie, Y; Funahashi, N; Ishizuka, S; Kobayashi, Y; Kotobuki, A; Mori, H; Nagasawa, K; Shimizu, N; Watanabe, Y | 1 |
| Kawano, S; Kohmura, H; Ohta, S; Takahashi, N | 1 |
| Amano, M; Goto, A; Hara, M; Sakai, A; Takahashi, N | 1 |
| Esumi, Y; Gunji, S; Ishikawa, H; Ishikawa, K; Jin, Y; Nakanomyo, H; Sonobe, J; Takaichi, M | 2 |
| Hiraoka, M; Kidono, M; Nakanomyo, H | 1 |
| Aramaki, M; Hiraoka, M; Ishikawa, K; Kawakami, A; Motohiro, T; Nakanomyo, H; Sakata, Y; Sasaki, H; Tominaga, K; Yamashita, F | 1 |
| Aramaki, M; Kawakami, A; Motohiro, T; Sakata, Y; Sasaki, H; Tominaga, K; Yamashita, F | 1 |
| Gomi, K; Hiraga, Y; Konishi, K; Nakayama, I; Ohmichi, M; Oizumi, K; Saito, A; Tamura, M; Tomizawa, M; Watanabe, A | 1 |
| Barbhaiya, RH; Gleason, CR; Martin, RR; Pittman, KA; Shyu, WC; Wilber, RB | 1 |
| Andrews, JM; Nye, K; O'Neill, P; Wise, R | 1 |
| Barbhaiya, RH; Gleason, CR; Martin, RR; Pittman, KA; Shukla, UA; Shyu, WC; Wilber, RB | 1 |
| Barbhaiya, RH; Gleason, CR; Pittman, KA; Shukla, UA; Shyu, WC; Wilber, RB | 1 |
| Barbhaiya, RH; Gleason, CR; Pittman, KA; Shukla, UA; Shyu, WC | 1 |
| Buck, RE; Chisholm, DR; Desiderio, JV; Kessler, RE; Leitner, F; Misiek, M; Pursiano, TA; Tsai, YH | 1 |
| Barry, AL; Jones, RN | 2 |
| Crokaert, F; Lismont, MJ; Van der Linden, MP; Yourassowsky, E | 1 |
| Niederriter, K; Norden, CW | 1 |
| Allen, ML; Atmar, RL; Ehrman, S; Freiman, J; Greenberg, SB; Kiefe, C | 1 |
| Edwards, B; Rissing, J; Steele, J | 1 |
| Chin, NX; Neu, HC | 1 |
| Eliopoulos, GM; Moellering, RC; Reiszner, E; Wennersten, C | 1 |
| Kayser, FH | 1 |
| Ando, S; Hirano, M; Kawaguchi, H; Kondo, S; Masuyoshi, S; Miyaki, T; Tomatsu, K | 1 |
| Hiraoka, M; Inoue, M; Masuyoshi, S; Mitsuhashi, S; Tomatsu, K | 1 |
| Aldridge, KE; Sanders, CV; Schiro, DD | 1 |
| Finkhouse, BD; Marks, MI; Scribner, RK | 1 |
| Abe, Y; Aburaki, S; Hoshi, H; Kawaguchi, H; Naito, T; Okumura, J; Tomatsu, K | 1 |
| Benfield, P; Wiseman, LR | 1 |
| Bonner, D; Denbleyker, K; Fung-Tomc, JC; Huczko, E; Kessler, R; Kolek, B; Minassian, B; Stickle, T | 1 |
| Anderson, RL; McKnight, JT; Rodman, DP | 1 |
| Barbhaiya, RH; Campbell, DA; Haddad, J; Khan, WN; Reilly, J; Shyu, WC; Tsai, Y | 1 |
| Gainer, RB | 1 |
| Wise, R | 1 |
| McCarty, JM | 1 |
| Ball, P | 1 |
| Kafetzis, DA | 1 |
| Nolen, T | 1 |
| Berche, P; Bingen, E; Boucot, I; Gehanno, P; Gres, JJ; Lambert-Zechovsky, N; Rollin, C | 1 |
| Doern, GV; Gerlach, EH; Hindler, J; Jones, RN; St Amand, R | 1 |
| Kearns, GL; Lowery, N; Wheeler, JG; Young, RA | 1 |
| Fung-Tomc, JC; Kessler, RE | 1 |
| Rodriguez, WJ; Wiedermann, BL | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Bass, JW; Chan, DS; Demers, DM | 1 |
| Adam, D; Hamilton, H; Materman, E; Milatovic, D | 1 |
| Barbhaiya, RH; Gleason, CR; Shyu, WC | 1 |
| Domann, DE | 1 |
| Brook, I; Gilmore, JD | 1 |
| Bale, MJ; Jones, RN | 1 |
| Stutman, HR | 1 |
| Barbhaiya, RH; Campbell, DA; Reilly, J; Shyu, WC; Wilber, RB | 1 |
| Cappelletty, DM; Rybak, MJ | 1 |
| Chadwick, EG; Hanekom, WA; Yogev, R | 1 |
| Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA | 1 |
| Ehrett, S; Hoyt-Sehnert, MJ; McCracken, GH; Shelton, S; Trujillo, M | 1 |
| Gordon, SM; Husni, RN; Keys, TF; Lavertu, P; Verbon, A | 1 |
| Aronovitz, G; Blumer, J; Dashefsky, B; Fiddes, R; McLinn, S; Nelson, K; Pichichero, ME | 1 |
| Astra, H; Kafetzis, DA; Mitropoulos, L | 1 |
| Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
| Brook, I; Foote, PA | 2 |
| Coleman, RT; Finney, K; Horowitz, CL; Murphy, TF; Standaert, BB; Taylor, MT; Walter, SM | 1 |
| Dahm, CE | 1 |
| Brook, I; Gober, AE | 1 |
| Pichichero, ME | 1 |
| Aronovitz, G | 1 |
| Angelilli, ML; Matsui, DM; Rieder, MJ; Toscani, M | 1 |
| Correa, N; McCracken, GH; Mejia, GI; Olsen, K; Realpe, T; Robledo, J; Trujillo, H; Trujillo, M | 1 |
| Banevicius, MA; Nicolau, DP; Nightingale, CH; Onyeji, CO; Tessier, PR; Zhong, M | 1 |
| Bettis, RB; Fogarty, CM; Griffin, TJ; Keyserling, CH; Nemeth, MA; Tack, KJ | 1 |
| Ambrose, PG; Quintiliani, R | 1 |
| Appelbaum, PC; Davies, TA; Dewasse, BE; Jacobs, MR; Nagai, K; Pankuch, GA | 1 |
| Block, SL; Kratzer, J; Nemeth, MA; Tack, KJ | 1 |
| Gooch, WM; Oddo, LP; Powers, JL | 1 |
| Hedrick, JA; Pierce, P; Schwartz, RH; Sher, LD | 1 |
| McCarty, JM; Pierce, PF | 1 |
| Aronovitz, GH; Brook, I; Pichichero, ME | 1 |
| Appelbaum, PC; Bozdogan, B; Clark, C; Dewasse, B; Jacobs, MR; Peric, M | 1 |
| Gryczyńska, D; Grzegorowski, M; Hassman-Poznańska, E; Niedzielska, G | 1 |
| Bhargava, S; Kabra, SK; Lodha, R | 1 |
| Jang, CH; Park, SY | 1 |
| Belet, N; Belet, U; Işlek, I; Küçüködük, S; Sunter, AT | 1 |
| Bagga, V; Gupta, N; Kar, K; Mehta, S; Moharana, AK; Mukherjee, A; Parmar, BJ | 1 |
| Chen, MJ; Hu, BJ; Li, HY; Liu, Y; Sun, ZY; Wang, H; Yu, YS | 1 |
| Gupta, N; Moharana, AK; Mukherjee, A | 1 |
| Jee, JP; Kim, CK; Kim, JK; Park, JS; Park, TH | 1 |
| Collet, JP; LeLorier, J; Quach, C | 1 |
| Baciewicz, AM; Chandra, R | 1 |
| Starostecka, B | 1 |
| Dagan, R; Regev-Yochay, G; Rubinstein, E | 1 |
| Bochnia, M; Dziewiszek, W; Orendorz-Fraczkowska, K; Smutnicka, D; Stankiewicz, M | 1 |
| Carlson, JA; Perlmutter, A; Richardson, D; Rohwedder, A; Tobin, E | 1 |
| Chiu, YL; Holas, C; Kapral, D; Notario, G | 1 |
| Abd El-Razeq, SA; Alarfaj, NA | 1 |
| Bina, JE; Bina, XR; Miller, MA; Wang, C | 1 |
| Ambrose, PG; Bajic, S; Bhavnani, SM; Booker, BM; Forrest, A; Jones, RN; Kelchlin, P; Smith, PF; Tsuji, B | 1 |
| Blumer, JL; Dul, M; O'Riordan, MA; Toltzis, H; Toltzis, P | 1 |
| Bilici, A; Cankir, Z; Karaduman, M | 1 |
| Arguedas, A; Dagan, R; Nicolau, DP; Pichichero, ME; Sutherland, CA | 1 |
| Jerath, N; Shetty, G | 1 |
| Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S | 1 |
| Leclair, MA; Maynard, B; St-Pierre, C | 1 |
| Can, NO | 1 |
| Cushing, SL; Gordon, KA; James, AL; Osborn, HA; Papsin, BC | 1 |
| Cao, X; Hou, D | 1 |
| Attia, KAM; El-Zeiny, MB; Nassar, MWI; Serag, A | 1 |
| Barlow, M; Meza, JC; Mira, PM; Nandipati, A | 1 |
| Deng, M; Du, A; Liu, H; Liu, M; Ma, JY; Meng, L; Wang, X; Yang, M; Zhang, Y; Zhao, H | 1 |
| Bergeron, MG; Bérubé, È; Boissinot, M; Boudreau, DK; Chabot, I; Corbeil, J; Déraspe, M; Domingo, MC; Dridi, B; Frenette, J; Gingras, H; Giroux, R; Huletsky, A; Iqbal, N; Leprohon, P; Ouameur, AA; Ouellette, M; Plante, PL; Raymond, F; Roy, PH; Simard, JL; Trottier, S | 1 |
| Attia, KA; El-Zeiny, MB; Nassar, MW; Serag, A | 2 |
| Chen, Y; Jia, FF; McLeod, HL; Ou-Yang, DS; Tan, ZR; Zhou, HH | 1 |
| Bergeron, MG; Boissinot, M; Corbeil, J; Déraspe, M; Raymond, F | 1 |
| Cao, X; Chen, J; Ding, Z; Pan, H | 1 |
| Bathini, L; Battistella, M; Garg, AX; Jain, AK; Jandoc, R; Kuwornu, P; Liu, A; McArthur, E; Muanda, FT; Sood, MM; Weir, MA | 1 |
| Alhaja, M; Dorrestein, PC; Jarmusch, AK; Knight, R; Liyanage, M; Ma, JD; Momper, JD; Tsunoda, SM; Vrbanac, A | 1 |
| Huang, Q; Liu, J; Song, J; Wei, F; Yang, L; Zhang, Z; Zhou, G | 1 |
| Årdal, C; Hudson, J; Kållberg, C; Klein, E; Laxminarayan, R; Lindbæk, M; Outterson, K; Røttingen, JA; Salvesen Blix, H | 1 |
24 review(s) available for cephalosporin c and cefzil
| Article | Year |
|---|---|
Pharmacology and pharmacokinetics of cefprozil.
Topics: Age Factors; Aged; Animals; Bacteria; Biological Availability; Cefprozil; Cephalosporins; Female; Food; Humans; Intestinal Absorption; Kidney Diseases; Liver Diseases; Male; Tissue Distribution | 1992 |
Review of the in vitro antibacterial activity of cefprozil, a new oral cephalosporin.
Topics: Cefprozil; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
Topics: Cefaclor; Cefprozil; Cephalosporins; Erythromycin; Humans; Penicillins; Pharyngitis; Tonsillitis | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Topics: Cefaclor; Cefprozil; Cellulitis; Cephalosporins; Erythromycin; Humans; Skin Diseases, Infectious | 1992 |
Safety profile of cefprozil.
Topics: Cefprozil; Cephalosporins; Diarrhea; Humans; Infections; Nausea | 1992 |
Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
Topics: Animals; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Humans; Microbial Sensitivity Tests; Otitis Media; Skin Diseases, Infectious; Urinary Tract Infections | 1993 |
A critical review of the new oral cephalosporins. Considerations and place in therapy.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Humans | 1994 |
Cefprozil, a new cephalosporin: its use in various clinical trials.
Topics: Cefprozil; Cephalosporins; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic | 1995 |
Comparative microbiological activity and pharmacokinetics of cefprozil.
Topics: Anti-Bacterial Agents; Bacteria; Cefprozil; Cephalosporins; Humans; Microbial Sensitivity Tests; Tissue Distribution | 1994 |
Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
Topics: Administration, Oral; Aged; beta-Lactamases; Cefprozil; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant | 1993 |
Cefprozil.
Topics: Adult; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Humans; Microbial Sensitivity Tests; Otitis Media; Pharyngitis | 1993 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic | 1996 |
Pott's puffy tumor due to Haemophilus influenzae: case report and review.
Topics: Aged; Aged, 80 and over; Cefprozil; Ceftriaxone; Cephalosporins; Follow-Up Studies; Frontal Bone; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Osteomyelitis; Radiography; Tomography Scanners, X-Ray Computed | 1996 |
Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil.
Topics: Adult; Bronchitis; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Tolerance; Humans; Infant; Otitis Media; Patient Satisfaction; Pharyngitis; Respiratory Tract Infections; Sinusitis; Tonsillitis | 1998 |
Cefprozil: a review.
Topics: Bronchitis; Cefprozil; Cephalosporins; Humans; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Skin Diseases, Infectious | 2003 |
A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Patient Satisfaction; Randomized Controlled Trials as Topic; Single-Blind Method; Smell; Suspensions; Taste | 2005 |
Redefining the management of pediatric tonsillopharyngitis with cefprozil.
Topics: Acute Disease; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Male; Pharyngitis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tonsillitis; Treatment Outcome | 2007 |
61 trial(s) available for cephalosporin c and cefzil
| Article | Year |
|---|---|
[Clinical studies on cefprozil granules in pediatric skin soft tissues infections].
Topics: Administration, Oral; Age Factors; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Impetigo; Infant; Male; Staphylococcus aureus | 1992 |
[Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections | 1992 |
[Pharmacokinetic and clinical studies of cefprozil fine granules in children].
Topics: Administration, Oral; Adolescent; Age Factors; Cefprozil; Cephalosporins; Child; Female; Humans; Lymphadenitis; Male; Otitis Media; Respiratory Tract Infections; Urinary Tract Infections | 1992 |
Short report: cefprozil for the eradication of Helicobacter pylori infection.
Topics: Adult; Cefprozil; Cephalosporins; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged | 1992 |
Oral absolute bioavailability and intravenous dose-proportionality of cefprozil in humans.
Topics: Adult; Biological Availability; Cefprozil; Cephalosporins; Humans; Infusions, Intravenous; Male | 1992 |
Comparative study of cefprozil and cefaclor in children with bacterial infections of skin and skin structures.
Topics: Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Prospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1992 |
[Clinical evaluation of a new oral cephem, cefprozil in children].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
[Clinical studies on cefprozil granules in pediatrics].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
[Laboratory and clinical studies on cefprozil granules in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
[Clinical study on cefprozil in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Hematologic Tests; Humans; Infant; Male | 1992 |
[Laboratory and clinical studies on cefprozil in the field of pediatrics].
Topics: Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests | 1992 |
[Pharmacokinetic, bacteriological and clinical studies on cefprozil in pediatric patients].
Topics: Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
[Laboratory and clinical studies of cefprozil in pediatric field].
Topics: Bacteria; Bacterial Infections; beta-Lactamases; Cefprozil; Cephalosporins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
[Overall clinical evaluation of cefprozil against infections in pediatric fields. Pediatric Study Group for Cefprozil].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Food; Hematologic Tests; Humans; Infant; Male | 1992 |
Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.
Topics: Administration, Oral; Adult; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Administration Schedule; Feces; Female; Humans; Intestines; Male; Metabolic Clearance Rate; Random Allocation | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
Topics: Cefaclor; Cefprozil; Cephalosporins; Erythromycin; Humans; Penicillins; Pharyngitis; Tonsillitis | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Topics: Cefaclor; Cefprozil; Cellulitis; Cephalosporins; Erythromycin; Humans; Skin Diseases, Infectious | 1992 |
Safety profile of cefprozil.
Topics: Cefprozil; Cephalosporins; Diarrhea; Humans; Infections; Nausea | 1992 |
Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Cefaclor; Cefprozil; Cephalosporins; Half-Life; Humans; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections | 1991 |
Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media with Effusion; Recurrence; Streptococcus pneumoniae | 1991 |
Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis.
Topics: Adolescent; Adult; Aged; Cefaclor; Cefprozil; Cephalosporins; Female; Humans; Male; Middle Aged; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1991 |
Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
Topics: Acute Disease; Adolescent; Adult; Cefaclor; Cefprozil; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Urinary Tract Infections | 1991 |
Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
Topics: Administration, Oral; Adult; Cefprozil; Cephalosporins; Drug Evaluation; Female; Humans; Isomerism; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis | 1991 |
Pharmacokinetics of cefprozil in healthy subjects and patients with hepatic impairment.
Topics: Administration, Oral; Adolescent; Adult; Cefprozil; Cephalosporins; Female; Humans; Isomerism; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1991 |
Pharmacokinetics of cefprozil in infants and children.
Topics: Administration, Oral; Cefprozil; Cephalosporins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Infant; Intestinal Absorption; Male; Microbial Sensitivity Tests | 1990 |
[Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia | 1990 |
Phase I study of multiple-dose cefprozil and comparison with cefaclor.
Topics: Adult; Body Fluids; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Drug Administration Schedule; Drug Evaluation; Humans; Male; Regression Analysis | 1990 |
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
Topics: Administration, Oral; Adolescent; Adult; Blister; Body Fluids; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Humans; Male | 1990 |
Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.
Topics: Adult; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Food; Humans; Intestinal Absorption; Male | 1990 |
Penetration of cefprozil into middle ear fluid of patients with otitis media.
Topics: Cefprozil; Cephalosporins; Child; Child, Preschool; Chronic Disease; Dose-Response Relationship, Drug; Exudates and Transudates; Female; Humans; Infant; Male; Middle Ear Ventilation; Otitis Media with Effusion | 1994 |
Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefprozil; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Neisseriaceae Infections; Otitis Media; Pneumococcal Infections; Streptococcus pneumoniae | 1994 |
Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef.
Topics: Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Single-Blind Method; Smell; Suspensions; Taste | 1994 |
Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis.
Topics: beta-Lactamases; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicillin V; Pharyngitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus; Tonsillitis | 1993 |
Effects of time of administration and posture on the pharmacokinetics of cefprozil.
Topics: Adult; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Drug Administration Schedule; Half-Life; Humans; Male; Posture; Sleep; Time Factors | 1993 |
Cefprozil treatment of persistent and recurrent acute otitis media.
Topics: Acute Disease; Administration, Oral; Cefprozil; Cephalosporins; Chi-Square Distribution; Child; Child, Preschool; Confidence Intervals; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media with Effusion; Prospective Studies; Recurrence | 1997 |
Five-day versus ten-day treatment of acute otitis media with cefprozil.
Topics: Acute Disease; Adolescent; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Otitis Media; Treatment Outcome | 1997 |
Effect of penicillin or cefprozil therapy on tonsillar flora.
Topics: Adolescent; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Palatine Tonsil; Penicillins; Prospective Studies; Recurrence; Tonsillitis | 1997 |
Comparison between cefprozil and penicillin to eradicate pharyngeal colonization of group A beta-hemolytic streptococci.
Topics: Adolescent; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Penicillins; Pharynx; Streptococcus pyogenes | 1998 |
Cefprozil concentrations in middle ear fluid of children with acute otitis media.
Topics: Acute Disease; Adolescent; Cefprozil; Cephalosporins; Child; Child, Preschool; Humans; Infant; Microbial Sensitivity Tests; Otitis Media with Effusion | 2000 |
Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bronchitis; Cefdinir; Cefprozil; Cephalosporins; Child; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Pharyngitis; Prospective Studies; Tonsillitis | 2000 |
Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media.
Topics: Acute Disease; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media; Treatment Outcome | 2000 |
Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Azithromycin; Cefdinir; Cefprozil; Cephalosporins; Child; Child, Preschool; Cross-Over Studies; Female; Humans; Male; Single-Blind Method; Smell; Suspensions; Taste | 2000 |
Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Infant; Male; Otitis Media; Single-Blind Method | 2001 |
Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefprozil; Cephalosporins; Clarithromycin; Demography; Double-Blind Method; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Treatment Outcome | 2001 |
Open-Label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis.
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin Ethylsuccinate; Female; Humans; Male; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2001 |
[Multicenter, open clinical investigation on using cefprozil in therapy of otitis media in children].
Topics: Acute Disease; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media; Treatment Outcome | 2003 |
Penetration of cefprozil to middle ear effusion in children with chronic otitis media with effusion.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Chronic Disease; Dose-Response Relationship, Drug; Ear, Middle; Female; Humans; Male; Otitis Media with Effusion | 2003 |
Comparison of trimethoprim-sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Cefadroxil; Cefprozil; Cephalosporins; Child; Drug Administration Schedule; Female; Humans; Male; Recurrence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2004 |
Efficacy and tolerability assessment of cefprozil in children with acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Treatment Outcome | 2004 |
Pediatric tonsillopharyngitis--an evaluation of cefprozil in Indian patients.
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child; Child, Preschool; Humans; Infant; Pharyngitis; Prospective Studies; Safety; Tonsillitis | 2004 |
Effect of antimicrobial therapy with amoxicillin and cefprozil on bacterial interference and beta-lactamase production in the adenoids.
Topics: Adenoids; Amoxicillin; Anti-Bacterial Agents; Antibiosis; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Haemophilus influenzae; Humans; Male; Otitis Media; Prospective Studies; Streptococcus pneumoniae; Streptococcus pyogenes | 2004 |
[Assessment of therapeutic effectiveness of Cefprozil in a short 5-day course of empirical antibiotic therapy in ambulatory patients with bacterial infections of the upper respiratory tract and otitis media].
Topics: Acute Disease; Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Otitis Media; Respiratory Tract Infections; Treatment Outcome | 2005 |
Comparative effects of single-dose ceftriaxone versus three oral antibiotic regimens on stool colonization by resistant bacilli in children.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefprozil; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance; Feces; Female; Gram-Negative Bacteria; Humans; Infant; Injections, Intramuscular; Male; Otitis Media | 2007 |
Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Area Under Curve; Cefprozil; Cephalosporins; Child, Preschool; Chromatography, High Pressure Liquid; Ear, Middle; Half-Life; Humans; Infant; Otitis Media | 2007 |
Effects of quercetin on pharmacokinetics of cefprozil in Chinese-Han male volunteers.
Topics: Adult; Anti-Bacterial Agents; Antioxidants; Cefprozil; Cephalosporins; Cross-Over Studies; Humans; Male; Quercetin; Volunteers | 2016 |
Tanshinone I and Tanshinone IIA/B attenuate LPS-induced mastitis via regulating the NF-κB.
Topics: Abietanes; Adult; Animals; Anti-Infective Agents; Apoptosis; Breast Feeding; Cefprozil; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mammary Glands, Animal; Mammary Glands, Human; Mastitis; Mice, Inbred BALB C; NF-kappa B p50 Subunit; Peroxidase; Tumor Necrosis Factor-alpha; Ultrasonography, Mammary | 2021 |
99 other study(ies) available for cephalosporin c and cefzil
| Article | Year |
|---|---|
[Clinical evaluation of cefprozil in children].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1992 |
[Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics].
Topics: Age Factors; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Respiratory Tract Infections; Urinary Tract Infections | 1992 |
[Clinical studies on cefprozil granules].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Respiratory Tract Infections | 1992 |
[Clinical studies on cefprozil in pediatrics].
Topics: Acute Disease; Administration, Oral; Bacteria; Bronchitis; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male; Tonsillitis; Urinary Tract Infections | 1992 |
[Clinical evaluation of cefprozil granules in pediatric field].
Topics: Administration, Oral; Age Factors; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Male; Thrombocytosis | 1992 |
[Clinical study on cefprozil fine granules].
Topics: Administration, Oral; Age Factors; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Eosinophilia; Female; Humans; Infant; Male | 1992 |
[Basic and clinical studies on cefprozil in pediatrics].
Topics: Administration, Oral; Age Factors; Bacteria; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male; Otitis Externa; Respiratory Tract Infections | 1992 |
[Therapeutic effects of cefprozil in the treatment of various infectious diseases in children].
Topics: Administration, Oral; Adolescent; Age Factors; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1992 |
Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad spectrum oral cephalosporin. Symposium. Amelia Island, Florida, 26-29 September 1991.
Topics: Cefprozil; Cephalosporins; Humans | 1992 |
Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
Topics: Adult; Cefprozil; Cephalosporins; Drug Interactions; Fasting; Food; Gastrointestinal Motility; Half-Life; Humans; Isomerism; Kidney Tubules; Male; Metabolic Clearance Rate; Metoclopramide; Middle Aged; Probenecid; Propantheline | 1992 |
[Pharmacokinetics of cefprozil in infant and adult beagle dogs].
Topics: Administration, Oral; Age Factors; Animals; Cefprozil; Cephalosporins; Dogs; Male | 1992 |
[The influence of cefprozil on intestinal bacterial flora].
Topics: Administration, Oral; Bacteria; beta-Lactamases; Cefprozil; Cephalosporins; Child; Child, Preschool; Feces; Female; Humans; Infant; Intestines; Male | 1992 |
[Pharmacokinetic study on oral antibiotics in pediatrics. III. A pharmacokinetic study on cefprozil in pediatrics].
Topics: Administration, Oral; Adolescent; Age Factors; Cefprozil; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Food; Humans; Infant | 1992 |
Excretion of cefprozil into human breast milk.
Topics: Administration, Oral; Cefprozil; Cephalosporins; Female; Humans; Milk, Human | 1992 |
Effect of antacid on the bioavailability of cefprozil.
Topics: Administration, Oral; Aluminum Hydroxide; Biological Availability; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Magnesium Hydroxide; Male | 1992 |
Cefprozil.
Topics: Bacterial Infections; Cefprozil; Cephalosporins; Humans | 1992 |
New antibiotics for skin and skin structure infections.
Topics: Cefprozil; Cephalosporins; Humans; Skin Diseases, Infectious | 1992 |
Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin.
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Drug Resistance, Microbial; Humans | 1992 |
Absolute bioavailability of cefprozil after oral administration in beagles.
Topics: Administration, Oral; Animals; Biological Availability; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Dogs; Half-Life; Infusions, Intravenous; Intestinal Absorption; Metabolic Clearance Rate | 1992 |
Inability of cephalothin testing to predict cefprozil susceptibility.
Topics: Cefprozil; Cephalosporins; Cephalothin; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests | 1991 |
Mode of antibacterial action of cefprozil, a new cephalosporin, on Escherichia coli, Serratia marcescens and Morganella morganii.
Topics: Bacteria; beta-Lactamases; Cefprozil; Cephalosporins; Escherichia coli; Peptidoglycan; Proteus; Serratia marcescens | 1991 |
In-vitro activity of cefprozil (BMY 28100) and loracarbef (LY 163892) against pathogens obtained from middle ear fluid.
Topics: Acute Disease; Cefprozil; Cephalosporins; Ear, Middle; Haemophilus influenzae; Moraxella catarrhalis; Otitis Media; Streptococcus pneumoniae | 1991 |
Simultaneous high-performance liquid chromatographic analysis of cefprozil diastereomers in a pharmacokinetic study.
Topics: Animals; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Protein Binding; Rats; Stereoisomerism | 1991 |
[Single dose oral toxicity study of BMY-28100 in juvenile rats and dogs].
Topics: Administration, Oral; Age Factors; Animals; Body Weight; Cefprozil; Cephalosporins; Diarrhea; Dogs; Eating; Female; Heart; Male; Organ Size; Rats; Rats, Inbred Strains; Spleen; Stomach; Vomiting | 1990 |
[Four-week repeated dose oral toxicity study of BMY-28100 in juvenile rats].
Topics: Administration, Oral; Age Factors; Animals; Body Weight; Brain; Cecum; Cefprozil; Cephalosporins; Diarrhea; Female; Heart; Hematologic Tests; Male; Organ Size; Rats; Rats, Inbred Strains; Time Factors | 1990 |
[Four-week repeated dose oral toxicity study of BMY-28100 in juvenile beagle dogs].
Topics: Administration, Oral; Age Factors; Animals; Bone Marrow; Bone Marrow Cells; Cecum; Cefprozil; Cephalosporins; Dogs; Female; Hematologic Tests; Male; Thymus Gland; Time Factors; Vomiting | 1990 |
[Immunological properties of BMY-28100 and cefepime].
Topics: Animals; Cefprozil; Cephalosporins; Coombs Test; Cross Reactions; Guinea Pigs; Hemagglutination Tests; Mice; Passive Cutaneous Anaphylaxis; Rats; Rats, Inbred Strains | 1990 |
[General pharmacology of BMY-28100].
Topics: Administration, Oral; Anesthetics, Local; Animals; Autonomic Nervous System; Cats; Cefprozil; Central Nervous System; Cephalosporins; Digestive System; Female; Guinea Pigs; Heart; In Vitro Techniques; Kidney; Male; Mice; Muscle, Smooth; Neuromuscular Junction; Rabbits; Rats; Rats, Inbred Strains; Respiration | 1990 |
[Studies on the pharmacokinetics of BMY-28100 (I)].
Topics: Administration, Oral; Animals; Autoradiography; Bile; Cefprozil; Cephalosporins; Female; Intestinal Absorption; Macaca fascicularis; Male; Protein Binding; Rats; Tissue Distribution | 1990 |
[Studies on the pharmacokinetics of BMY-28100 (II)].
Topics: Administration, Oral; Animals; Autoradiography; Cefprozil; Cephalosporins; Female; Fetus; Male; Maternal-Fetal Exchange; Milk; Pregnancy; Rats; Tissue Distribution | 1990 |
[Microbiological assay method of BMY-28100 and some other cephem antibiotic in serum and tissues. Development of new sample preparation with Evan's blue, a high albumin binding dye].
Topics: Animals; Biological Assay; Cefadroxil; Cefazolin; Cefprozil; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Evans Blue; Humans; Liver; Male; Rats; Rats, Inbred Strains; Serum Albumin | 1990 |
[Pharmacokinetics of BMY-28100 in multiple administration].
Topics: Administration, Oral; Adult; Capsules; Cefprozil; Cephalosporins; Humans; Male; Reference Values | 1990 |
[Effect of BMY-28100 on bacterial flora in adult human feces].
Topics: Administration, Oral; Adult; Bacteria; Capsules; Cefprozil; Cephalosporins; Feces; Humans; Male | 1990 |
Phase I study of single-dose BMY-28100, a new oral cephalosporin.
Topics: Adult; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Drug Evaluation; Humans; Male | 1990 |
Pharmacokinetics and tissue penetration of cefprozil.
Topics: Adult; Blister; Body Fluids; Cefprozil; Cephalosporins; Humans; Male; Tissue Distribution | 1990 |
BMY 28100, a new oral cephalosporin.
Topics: Animals; Bacteria; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Clostridium; Enterobacteriaceae; Haemophilus influenzae; Kinetics; Listeria monocytogenes; Male; Mice; Microbial Sensitivity Tests; Neisseriaceae; Propionibacterium acnes; Staphylococcus; Streptococcus | 1987 |
Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
Topics: Cefprozil; Cephalosporins; Enterococcus faecalis; Escherichia coli; Haemophilus influenzae; Microbial Sensitivity Tests; Providencia; Pseudomonas aeruginosa; Quality Control; Regression Analysis; Staphylococcus aureus | 1987 |
Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid against Branhamella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefprozil; Cephalosporins; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Humans; Moraxella catarrhalis; Respiratory Tract Infections | 1988 |
In vitro activity of BMY-28100, a new oral cephalosporin.
Topics: Cefaclor; Cefprozil; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Staphylococcus aureus | 1988 |
BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
Topics: Administration, Oral; Bacteria, Anaerobic; beta-Lactamases; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1988 |
Effect of BMY-28100, a new cephalosporin, on Staphylococcus aureus nasal carriage.
Topics: Adult; Carrier State; Cefprozil; Cephalosporins; Humans; Male; Nasal Cavity; Staphylococcal Infections; Staphylococcus aureus | 1987 |
In vitro activity of BMY 28100, a new oral cephalosporin.
Topics: Bacteria; Cefprozil; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella; Staphylococcus aureus; Streptococcus pneumoniae | 1987 |
Comparative antibacterial activity of a new oral cephalosporin, BMY-28100.
Topics: Bacteria; beta-Lactamases; Cefprozil; Cephalosporins; Drug Stability; Microbial Sensitivity Tests | 1987 |
In vitro activity of BMY-28100, a new oral cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Microbial Sensitivity Tests | 1987 |
Comparative antibacterial activity of the new oral cephalosporin BMY-28100.
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella; Staphylococcus; Streptococcus | 1987 |
In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
Topics: Animals; Bacteria, Aerobic; Bacterial Infections; beta-Lactamases; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Mice; Microbial Sensitivity Tests; Rats | 1987 |
In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.
Topics: Cefaclor; Cefprozil; Cephalosporins; Clostridium; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillinase; Staphylococcus; Streptococcus | 1987 |
Comparative in vitro activity of the new oral cephalosporin BMY-28100.
Topics: Anti-Bacterial Agents; Bacteria; Cefprozil; Cephalosporins; Digestive System; Humans; Microbial Sensitivity Tests; Respiratory System; Skin | 1987 |
In vitro activity of BMY-28100 against common isolates from pediatric infections.
Topics: Bacteria; Bacterial Infections; Cefprozil; Cephalosporins; Child; Humans; Microbial Sensitivity Tests | 1987 |
Synthesis and structure-activity relationships of a new oral cephalosporin, BMY-28100 and related compounds.
Topics: Animals; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Isomerism; Male; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship | 1987 |
Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Cefprozil; Cephalosporins; Macrolides; Microbial Sensitivity Tests | 1995 |
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control | 1994 |
Serum sickness-like reactions associated with cefprozil therapy.
Topics: Adult; Bronchitis; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Otitis Media; Serum Sickness; Sinusitis | 1994 |
Susceptibility of United States clinical trial isolates to cefprozil and cefaclor.
Topics: Cefaclor; Cefprozil; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 1994 |
Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
Topics: Administration, Oral; Cefdinir; Cefprozil; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Evaluation Studies as Topic; False Positive Reactions; Humans; Microbial Sensitivity Tests; Proteus vulgaris; Providencia | 1994 |
Cefprozil breakpoint.
Topics: Cefprozil; Cephalosporins; Humans; Microbial Sensitivity Tests | 1993 |
Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.
Topics: Abscess; Animals; beta-Lactamases; Cefprozil; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Hemolysis; Mice; Mice, Inbred Strains; Penicillins; Staphylococcus aureus; Streptococcal Infections; Streptococcus agalactiae; Tonsillitis | 1993 |
Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
Topics: Anti-Infective Agents; Cefdinir; Cefepime; Cefmetazole; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones | 1993 |
Penetration of cefprozil into tonsillar and adenoidal tissues.
Topics: Adenoidectomy; Adenoids; Adolescent; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Palatine Tonsil; Pharynx; Stereoisomerism; Tonsillectomy | 1993 |
[Cefprozil].
Topics: Cefprozil; Cephalosporins | 1996 |
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Colony-Forming Units Assay; Humans; Microbial Sensitivity Tests; Models, Theoretical; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Pneumococcal parotitis in a human immunodeficiency virus-infected child.
Topics: Cefprozil; Cephalosporins; Child, Preschool; Diagnosis, Differential; Female; Fever; HIV Infections; Humans; Hypertrophy; Parotid Gland; Parotitis; Pneumococcal Infections; Streptococcus pneumoniae | 1995 |
Safety and efficacy of cefprozil as part of a parenteral-oral antibiotic regimen for the treatment of suppurative skeletal infections in children.
Topics: Administration, Oral; Bacterial Infections; Biopsy, Needle; Bone Diseases; Cefprozil; Cephalosporins; Child; Child, Preschool; Humans; Joint Diseases; Joints; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1996 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Which antibiotics for acute sinusitis?
Topics: Acute Disease; Adult; Cefprozil; Cephalosporins; Child; Child, Preschool; Humans; Infant; Sinusitis | 1998 |
Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibiosis; Cefprozil; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Infant; Male; Nasopharynx; Otitis Media | 1998 |
Cefprozil and respiratory tract infections in children.
Topics: Cefprozil; Cephalosporins; Child; Humans; Respiratory Tract Infections | 1998 |
Palatability of oral antibiotics among children in an urban primary care center.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Cefixime; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Flavoring Agents; Humans; Male; Pain Measurement; Patient Acceptance of Health Care; Taste; Urban Population | 2000 |
Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations.
Topics: Animals; Cefprozil; Cephalosporins; Disease Models, Animal; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 2000 |
Limitations of single point pharmacodynamic analysis.
Topics: Cefprozil; Cephalosporins; Child, Preschool; Haemophilus influenzae; Humans; Infant; Labyrinthine Fluids; Microbial Sensitivity Tests; Monte Carlo Method; Sensitivity and Specificity; Streptococcus pneumoniae | 2000 |
In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Cefprozil; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Microbial Sensitivity Tests; Mutation; Serotyping; Streptococcus pneumoniae | 2000 |
In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
Topics: Amino Acid Sequence; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Genes, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial | 2002 |
[Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003].
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Child, Preschool; China; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Ofloxacin; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2004 |
HPLC method for simultaneous determination of cefprozil diastereomers in human plasma.
Topics: Biological Availability; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 2004 |
Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefprozil; Cephalosporins; Child; Child, Preschool; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Otitis Media; Quebec; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Cefprozil-induced rash in infectious mononucleosis.
Topics: Adolescent; Cefprozil; Cephalosporins; Exanthema; Female; Humans; Infectious Mononucleosis | 2005 |
Resistant organisms and otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefprozil; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Otitis Media; Risk Assessment; Sensitivity and Specificity; Streptococcus pneumoniae | 2005 |
[Cefprozil in the treatment of chronic maxillary sinusitis. Clinical and microbiological effectiveness and penetration into sinuses examination].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Chronic Disease; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome | 2005 |
Adverse antibiotic-induced eruptions associated with epstein barr virus infection and showing Kikuchi-Fujimoto disease-like histology.
Topics: Adult; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Drug Eruptions; Female; Herpesvirus 4, Human; Histiocytic Necrotizing Lymphadenitis; Humans; In Situ Hybridization; Infectious Mononucleosis; Lymph Nodes; Male; Minocycline; RNA, Viral; Skin | 2006 |
Flow-injection chemiluminescent determination of cefprozil using Tris (2,2'-bipyridyl) ruthenium (II)-permanganate system.
Topics: Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Colorimetry; Flow Injection Analysis; Luminescent Measurements; Potassium Permanganate | 2006 |
The Bla2 beta-lactamase from the live-vaccine strain of Francisella tularensis encodes a functional protein that is only active against penicillin-class beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Vaccines; beta-Lactamases; Blotting, Western; Cefprozil; Cephalosporins; Francisella tularensis; Genetic Vectors; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins | 2006 |
Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model.
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Dose-Response Relationship, Drug; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 2006 |
A rare case of hepatitis associated with cefprozil therapy.
Topics: Adolescent; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Chemical and Drug Induced Liver Injury; Female; Humans; Pharyngitis; Tonsillitis | 2007 |
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins | 2008 |
Acute generalized exanthematous pustulosis with severe organ dysfunction.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Biopsy; Cefprozil; Cephalosporins; Exanthema; Humans; Male; Middle Aged; Skin; Skin Diseases, Vesiculobullous; Spider Bites; Stroke Volume; Systemic Inflammatory Response Syndrome; Tachycardia, Sinus | 2009 |
HPLC determination of cefprozil in tablets using monolithic and C18 silica columns.
Topics: Anti-Bacterial Agents; Cefprozil; Cephalosporins; Chromatography, High Pressure Liquid; Tablets | 2011 |
The management of acute mastoiditis in children with cochlear implants: saving the device.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cefuroxime; Cephalexin; Cephalosporins; Child; Child, Preschool; Clindamycin; Cochlear Implantation; Cochlear Implants; Drainage; Female; Hearing Loss, Sensorineural; Humans; Infant; Infusions, Intravenous; Male; Mastoiditis; Otitis Media; Prosthesis-Related Infections; Retrospective Studies; Risk Factors | 2013 |
Synthesis of two thermo-responsive copolymers forming recyclable aqueous two-phase systems and its application in cefprozil partition.
Topics: Acrylamides; Cefprozil; Cephalosporins; Lactams; Particle Size; Polymers; Salts; Temperature; Water | 2014 |
Different approaches in manipulating ratio spectra applied for the analysis of Cefprozil in presence of its alkaline-induced degradation product: a comparative study.
Topics: Alkalies; Calibration; Cefprozil; Cephalosporins; Reference Standards; Regression Analysis; Reproducibility of Results; Spectrophotometry | 2015 |
Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change.
Topics: Adaptation, Physiological; Alleles; Anti-Bacterial Agents; beta-Lactams; Cefprozil; Cephalosporins; Drug Resistance, Microbial; Genes, Bacterial | 2015 |
An LC-MS/MS method for simultaneous determination of cefprozil diastereomers in human plasma and its application for the bioequivalence study of two cefprozil tablets in healthy Chinese volunteers.
Topics: Adult; Asian People; Cefprozil; Cephalosporins; China; Chromatography, Liquid; Humans; Linear Models; Male; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult | 2016 |
The initial state of the human gut microbiome determines its reshaping by antibiotics.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Cefprozil; Cephalosporins; Feces; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Metagenomics; Young Adult | 2016 |
Stability indicating methods for the analysis of cefprozil in the presence of its alkaline induced degradation product.
Topics: Algorithms; Alkalies; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Drug Stability; Least-Squares Analysis; Multivariate Analysis; Spectrophotometry | 2016 |
Partial recovery of microbiomes after antibiotic treatment.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Cefprozil; Cephalosporins; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans | 2016 |
Molecular and Quantum Mechanical Study for the Separation of Cefprozil in the Presence of Its Alkaline Degradation Product Using RP-HPLC with UV Detection.
Topics: Cefprozil; Cephalosporins; Chromatography, Reverse-Phase; Hydrophobic and Hydrophilic Interactions; Models, Chemical; Piperazines; Quantum Theory; Sodium Hydroxide; Spectrophotometry, Ultraviolet | 2017 |
Development of pH-responsive polymer and citrate aqueous two-phase system for extractive bioconversion of cefprozil.
Topics: Cefprozil; Cephalosporins; Chemical Fractionation; Citric Acid; Hydrogen-Ion Concentration; Models, Molecular; Molecular Conformation; Polymers; Temperature; Viscosity; Water | 2017 |
Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefprozil; Cefuroxime; Cephalexin; Cephalosporins; Databases, Factual; Emergency Service, Hospital; Female; Glomerular Filtration Rate; Hospitalization; Humans; Male; Mortality; Renal Insufficiency, Chronic; Retrospective Studies; Treatment Failure | 2019 |
Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Feces; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Metabolomics; Middle Aged; Omeprazole; Pharmacogenomic Testing; Pharmacogenomic Variants; Prospective Studies; Young Adult | 2020 |
The effect of generic market entry on antibiotic prescriptions in the United States.
Topics: Anti-Bacterial Agents; Aztreonam; Cefdinir; Cefprozil; Cephalosporins; Costs and Cost Analysis; Databases, Pharmaceutical; Drug Costs; Drug Industry; Drug Prescriptions; Drugs, Generic; Humans; United States | 2021 |